# The Amputation Surgical Site Infection Trial (ASSIT)

> **NCT02018094** · PHASE4 · COMPLETED · sponsor: **Hull University Teaching Hospitals NHS Trust** · enrollment: 160 (actual)

## Conditions studied

- Wound Infection
- Amputation Wound

## Interventions

- **DRUG:** Co-amoxiclav
- **DRUG:** Iodine
- **DRUG:** Metronidazole
- **DRUG:** Chlorhexidine
- **DRUG:** Teicoplanin
- **DRUG:** Clindamycin

## Key facts

- **NCT ID:** NCT02018094
- **Lead sponsor:** Hull University Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-08
- **Primary completion:** 2014-03-01
- **Final completion:** 2017-01-02
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2019-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02018094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02018094, "The Amputation Surgical Site Infection Trial (ASSIT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02018094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*